14 real estate
strategies to reduce
costs and fuel
Life Sciences R&D

Practical approaches that free up available capital

In the wake of a global pandemic, the life sciences industry has risen to the occasion, supplying vital medicines, developing new therapeutics, diagnostics and vaccines in the fight against COVID-19. However, it’s also disrupted research, clinical trials and supply chains at a time when the sector was contending with significant challenges, including financial.

Operational efficiency is more important now than ever. Below are ways to leverage your third-largest expense – real estate and facilities – to reduce costs and improve cash flow, opening up much-needed resources to invest in R&D.

14 Strategies to help your company grow

Click on a title below to learn more about each cost savings opportunity and the time frame to realize savings:

Download our comprehensive guidebook, 14 real estate strategies to reduce costs and fuel Life Sciences R&D, for an in-depth look into how you can reduce costs, recapture revenue and thrive.

Fill out this form to download our guide

Ready for your life sciences organization to reduce costs, recapture revenue and invest in R&D? Contact us to see how we can help.



Jones Lang LaSalle (JLL), together with its subsidiaries and affiliates, is a leading global provider of real estate and investment management services. We take our responsibility to protect the personal information provided to us seriously.

Generally the personal information we collect from you are for the purposes of dealing with your enquiry.

We endeavor to keep your personal information secure with appropriate level of security and keep for as long as we need it for legitimate business or legal reasons. We will then delete it safely and securely. For more information about how JLL processes your personal data, please view our privacy statement.